Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Ankyra Therapeutics Presents Preliminary Canine Clinical Data with cANK-101 Supporting Therapeutic Potential of Anchored Immunotherapy
Wednesday, April 19, 2023Ankyra Therapeutics a preclinicalstage oncology company developing anchored immunotherapies to improve the therapeutic window for cytokine drugs announced today that it will be presenting data from a canine clinical trial of cANK at the American Asso...
Resilia Pharmaceuticals Announces Relaunch of Solace® Eczema Cream On Amazon®
Wednesday, April 19, 2023Resilia Pharmaceuticals Inc announced today that it has relaunched Solace Eczema Cream on Amazon and restored the supply of this product that had formerly only been available by prescription Solace is marketed under Resilias Santefirm Consumer Healt...
Basilea provides update on New Drug Application to the US Food and Drug Administration for antibiotic ceftobiprole
Tuesday, April 18, 2023Basilea Pharmaceutica Ltd a commercialstage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections provided an updated timeline for its New Drug Application NDA submission for its antibiotic ce...
Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform
Tuesday, April 18, 2023Dyadic International Inc a global biotechnology company focused on building innovative microbial protein production platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective affordable and accessi...
Molecular and digital pathology innovators Xyall and Indica Labs forge global collaboration to transform precision oncology workflows
Monday, April 17, 2023Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology It unites Xyalls unique automated tissue dissection solutions with Indica Labs AIpowered diagnostic digital pa...
Macomics Presents its ENIGMAC™ Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR
Monday, April 17, 2023Macomics Ltd a leader in macrophage drug discovery has presented data demonstrating the power of its ENIGMACTM macrophage drug discovery platform at the American Association for Cancer Researchs Annual Meeting AACR April Florida Macomics is exploit...
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
Monday, April 17, 2023Avenue Therapeutics Inc a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases today announced that it has received official meeting minutes from the Type C m...
Phase Genomics Collaborates with Element Biosciences to Optimize Cytogenomics for Liquid and Solid Tumor Samples
Friday, April 14, 2023Phase Genomics Inc a leading developer of cuttingedge genomic solutions and Element Biosciences the developer of an innovative DNA sequencing platform disrupting genomics today released new details of their first collaboration leveraging Phase Genomi...
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
Wednesday, April 12, 2023ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further largescale manufacturing of clinical material for IOS ImmunOs lead program for the treatment of cancer ProBioGen previously developed the cell line and the man...
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
Wednesday, April 12, 2023Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease today announced it has entered into a translational c...
